Benzinga | Jul 28, 2021 04:25PM EDT

CONMED Raises FY21 Adj. EPS Guidance From $3.05-$3.20 To $3.15-$3.25 vs $3.15 Est., Raises Sales Guidance From $1.0B-$1.03B To $1.015B-$1.035B $1.02B Est.

2021 Outlook

Based on its first six-month results, the Company is increasing its guidance for the full year 2021 and now expects revenue between $1.015 billion and $1.035 billion, compared to its prior guidance of between $1.0 billion and $1.03 billion. Based on recent exchange rates, the Company continues to expect the positive impact to 2021 sales from foreign exchange in the range of 50 to 100 basis points.

The Company now expects full-year 2021 adjusted diluted net earnings per share in the range of $3.15 to $3.25, compared to its prior range of $3.05 to $3.20.